NO20003881D0 - Bibapcitid-baserte farmasøytiske sammensetninger for avbildning og behandling av thromber - Google Patents

Bibapcitid-baserte farmasøytiske sammensetninger for avbildning og behandling av thromber

Info

Publication number
NO20003881D0
NO20003881D0 NO20003881A NO20003881A NO20003881D0 NO 20003881 D0 NO20003881 D0 NO 20003881D0 NO 20003881 A NO20003881 A NO 20003881A NO 20003881 A NO20003881 A NO 20003881A NO 20003881 D0 NO20003881 D0 NO 20003881D0
Authority
NO
Norway
Prior art keywords
bibapcitide
thrombi
imaging
treatment
pharmaceutical compositions
Prior art date
Application number
NO20003881A
Other languages
English (en)
Other versions
NO20003881L (no
Inventor
Richard T Dean
John Lister-James
Original Assignee
Diatide Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB9802681A external-priority patent/GB9802681D0/en
Application filed by Diatide Inc filed Critical Diatide Inc
Publication of NO20003881D0 publication Critical patent/NO20003881D0/no
Publication of NO20003881L publication Critical patent/NO20003881L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/08Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20003881A 1998-02-06 2000-07-28 Bibapcitid-baserte farmasøytiske sammensetninger for avbildning og behandling av thromber NO20003881L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/020,086 US6028056A (en) 1998-02-06 1998-02-06 Pharmaceutical compositions for imaging and treating thrombi
GB9802681A GB9802681D0 (en) 1998-02-06 1998-02-06 Pharmaceutical compoations for imaging and treating thrombi
PCT/US1999/002583 WO1999039747A1 (en) 1998-02-06 1999-02-05 Bipapcitide-based pharmaceutical compositions for imaging and treating thrombi

Publications (2)

Publication Number Publication Date
NO20003881D0 true NO20003881D0 (no) 2000-07-28
NO20003881L NO20003881L (no) 2000-07-28

Family

ID=26313082

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20003881A NO20003881L (no) 1998-02-06 2000-07-28 Bibapcitid-baserte farmasøytiske sammensetninger for avbildning og behandling av thromber

Country Status (26)

Country Link
US (1) US6028056A (no)
EP (1) EP1053027B1 (no)
JP (1) JP2003532617A (no)
KR (1) KR100452390B1 (no)
CN (1) CN1103606C (no)
AR (1) AR018546A1 (no)
AT (1) ATE279214T1 (no)
AU (1) AU761778B2 (no)
BR (1) BR9908352A (no)
CA (1) CA2319544C (no)
DE (1) DE69921096T2 (no)
DK (1) DK1053027T3 (no)
EA (1) EA005406B1 (no)
ES (1) ES2229681T3 (no)
HK (1) HK1032198A1 (no)
HU (1) HUP0100887A3 (no)
IL (1) IL137076A (no)
NO (1) NO20003881L (no)
NZ (1) NZ505085A (no)
PE (1) PE20000250A1 (no)
PL (1) PL342253A1 (no)
PT (1) PT1053027E (no)
SI (1) SI1053027T1 (no)
SK (1) SK284463B6 (no)
TW (1) TWI246425B (no)
WO (1) WO1999039747A1 (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX352546B (es) 2011-08-17 2017-11-29 Piramal Imaging Sa Compuesto para la union de glicoproteina iib/iiia especifica a plaquetas y su uso para la formacion de imagenes de un trombo.
CN105189521A (zh) 2013-02-12 2015-12-23 拜耳医药股份公司 结合至血小板特异性糖蛋白IIb/IIIa的金属螯合化合物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5830856A (en) * 1991-02-08 1998-11-03 Diatide, Inc. Radiolabeled compounds for thrombus imaging
US5645815A (en) * 1991-02-08 1997-07-08 Diatide, Inc. Radiolabled compounds for thrombus imaging
US5508020A (en) * 1992-06-05 1996-04-16 Diatech, Inc. Technetium-99M labeled peptides for imaging
EP0641222B1 (en) * 1992-05-21 2000-09-06 Diatide, Inc. TECHNETIUM-99m LABELED PEPTIDES FOR THROMBUS IMAGING

Also Published As

Publication number Publication date
TWI246425B (en) 2006-01-01
PL342253A1 (en) 2001-06-04
BR9908352A (pt) 2000-11-28
IL137076A0 (en) 2001-06-14
EP1053027B1 (en) 2004-10-13
PT1053027E (pt) 2005-01-31
NO20003881L (no) 2000-07-28
CA2319544C (en) 2006-07-04
EA005406B1 (ru) 2005-02-24
AU2660499A (en) 1999-08-23
ES2229681T3 (es) 2005-04-16
AU761778B2 (en) 2003-06-12
SK284463B6 (sk) 2005-04-01
SI1053027T1 (en) 2005-04-30
NZ505085A (en) 2002-10-25
PE20000250A1 (es) 2000-06-02
CA2319544A1 (en) 1999-08-12
HUP0100887A3 (en) 2003-08-28
ATE279214T1 (de) 2004-10-15
DK1053027T3 (da) 2005-01-17
KR20010040676A (ko) 2001-05-15
DE69921096D1 (de) 2004-11-18
EP1053027A1 (en) 2000-11-22
CN1103606C (zh) 2003-03-26
KR100452390B1 (ko) 2004-10-08
WO1999039747A1 (en) 1999-08-12
JP2003532617A (ja) 2003-11-05
HK1032198A1 (en) 2001-07-13
SK11392000A3 (sk) 2001-03-12
US6028056A (en) 2000-02-22
AR018546A1 (es) 2001-11-28
DE69921096T2 (de) 2006-02-02
IL137076A (en) 2004-08-31
HUP0100887A2 (hu) 2001-06-28
EA200000820A1 (ru) 2001-02-26
CN1290179A (zh) 2001-04-04

Similar Documents

Publication Publication Date Title
NO994778D0 (no) FremgangsmÕter og sammensetninger for behandling av tarmbetennelse
NO20022531D0 (no) Vaksine for forebyggelse og behandling av Alzheimer og amyloidrelaterte sykdommer
NO982311D0 (no) Sammensetninger og fremgangsmÕter for forhindring og behandling av oral mukositt
NO20015773D0 (no) Forhindring og behandling av amyloidogen sykdom
NO20014046D0 (no) Gabapentinderivater for forhindring og behandling av visceral smerte
NO984107D0 (no) Kappa agnostiske forbindelser og farmasöytiske ormuleringer derav
IL147217A0 (en) New spirooxindole derivatives and pharmaceutical compositions containing the same for treatment of pain
DE69822410D1 (de) Modularkatheter zur Abbildung und Behandlung und Montageverfahren
DK0956858T3 (da) Farmaceutiske præparater indeholdende lactobacilli til behandling af vaginale infektioner
DK1994937T3 (da) Forebyggelse og behandling af amyloidogen sygdom
NO996352D0 (no) <Kappa>-antagenist-forbindelser, farmasoeytiske sammensetninger og fremgangsmåte for forebygging og behandling av pruritus
NO20022974L (no) Anvendelse av biologisk aktive vitamin D-forbindelser for forhindring og behandling av inflammatorisk tarmsykdom
NO20004741D0 (no) Farmasøytiske blandinger for forlenget peptidfrigjøring og fremstillingsmetode
NO20014314D0 (no) Blandinger og metoder for behandling av stafylokokkisk infeksjon
NO20015542L (no) Fremgangsmåte for fremstilling og anvendelse av N- desmetylzopikloner
NO20012963D0 (no) Fremgangsmåte for fremstilling av 3-alkanoylindoler og 3- alkylindoler
NO20015516D0 (no) Preparater og anvendelser av ET743 for behandling av kreft
DE69620691D1 (de) Therapeutisches Mittel zur Behandlung der Hypercholesterinämie
NO983512D0 (no) Midler for behandling og forhindring av AIDS
HUP0300402A3 (en) Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain and pharmaceutical compositions containing them
NO994631D0 (no) Fremgangsmaater og sammensetninger for behandling av eggstokkreft
NO993784L (no) Farmasöytiske blandinger inneholdende ibuprofen og domperidon for behandling av migrene
NO20001758D0 (no) Fremgangsmåter og blandinger for behandling av leddgikt
NO995406L (no) Farmasøytiske sammensetninger av tizoksanid og nitazoksanid
NO20020369L (no) Sammensetninger for forebyggelse og behandling av nyredysfunksjoner og -sykdommer

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application